QTRX.O (QTRX.O) News
Follow QTRX.O (QTRX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Quanterix expands China diagnostics partnership with Innovita after NMPA clears SIMOA HD-X and SR-X
Quanterix said Innovita secured NMPA clearances for its SIMOA HD-X and SR-X instruments and four neurology biomarker kits, enabling wider rollout of SIMOA systems and blood-based Alzheimer’s testing in China. Innovita pl
EQUITY | Oct 07, 2026, 12:02 PM UTC
M
Quanterix and Innovita win NMPA approvals for China IVD access
Innovita received NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker kits in China. The companies said the approvals expand access to SIMOA-powered blood-based testing.
EQUITY | Oct 07, 2026, 12:00 PM UTC